Press "Enter" to skip to content

New patent for Mallinckrodt Hosp drug INOMAX

0
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for INOMAX
Annual Drug Patent Expirations for INOMAX

Inomax is a drug marketed by Mallinckrodt Hosp and is included in one NDA. It is available from one supplier. There are fifteen patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for INOMAX.

The generic ingredient in INOMAX is nitric oxide. One supplier is listed for this compound. Additional details are available on the nitric oxide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

    Leave a Reply

    DrugPatentWatch - Make Better Decisions